Symbol="KRON"
AssetType="Common Stock"
Name="Kronos BioÂ Inc"
Description="Kronos Bio, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of new cancer therapies. The company is headquartered in San Mateo, California."
CIK="1741830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1300 S. EL CAMINO REAL, SUITE 300, SAN MATEO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="83976000"
EBITDA="-125590000"
PERatio="None"
PEGRatio="None"
BookValue="3.499"
DividendPerShare="0"
DividendYield="0"
EPS="-1.97"
RevenuePerShareTTM="0.054"
ProfitMargin="0"
OperatingMarginTTM="-41.47"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-0.484"
RevenueTTM="3084000"
GrossProfitTTM="0"
DilutedEPSTTM="-1.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.419"
EVToRevenue="-"
EVToEBITDA="0.701"
Beta="1.486"
num_52WeekHigh="4.99"
num_52WeekLow="1.2"
num_50DayMovingAverage="1.786"
num_200DayMovingAverage="1.819"
SharesOutstanding="58316000"
DividendDate="None"
ExDividendDate="None"
symbol="KRON"
open="1.45"
high="1.48"
low="1.39"
price="1.42"
volume="103364.00"
latest_trading_day="2023-08-22"
previous_close="1.44"
change="-0.02"
change_percent="-1.3889%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="35"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="65"
Volume_recent_avg="327972"
Change_recent_avg="0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
